Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

4(67%)

Results Posted

50%(1 trials)

Phase Distribution

Ph early_phase_1

17%

Ph not_applicable

17%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

1(25.0%)

Phase 1Safety & dosage

2(50.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(2)

Detailed Status

Recruiting3

Completed2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Early Phase 11 (25.0%)

Phase 12 (50.0%)

N/A1 (25.0%)

Trials by Status

active_not_recruiting117%

completed233%

recruiting350%

Recent Activity

4 active trials

Showing 5 of 6

recruitingphase_1

Clinical Trials (6)

Showing 6 of 6 trials

NCT07800520Phase 1

Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder

Recruiting

NCT05683184Phase 1

OMAR Opioid Use Disorder

Recruiting

NCT03539575Not Applicable

CB1R in Synthetic Psychoactive Cannabinoids

Active Not Recruiting

NCT01730781

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Recruiting

NCT03104257

The Neural Correlates of Cannabis Use

Completed

NCT03204305Early Phase 1

Brain Imaging of Cannabinoid Receptors

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6